Back

Financial Outcomes and Community Benefit in the 340B Program: Comparing 340B and Non-340B Hospitals

2026-02-17 health policy Title + abstract only
View on medRxiv
Show abstract

BackgroundThe 340B Drug Pricing Program was established to expand access to care for low-income and uninsured patients by allowing safety-net hospitals and clinics to purchase outpatient drugs at discounted prices. Over time, the program has expanded substantially, raising questions about whether participating hospitals are meeting the programs intended objectives. MethodsUsing 2023 hospital financial data from the RAND Corporation, we conducted cross-sectional descriptive comparisons of 340B a...

Predicted journal destinations